PHARMARON Proposes Capital Increase

Stock News03-31

PHARMARON (03759) has announced that its board of directors has resolved and approved several proposals, including: (i) a recommendation to increase the company's registered capital; and (ii) a recommendation to amend the company's articles of association. This decision follows (i) the placement of a total of 58.4408 million new H shares on January 22, 2026; and (ii) the registration and listing of a total of 647,300 restricted A shares, which vested under the fourth vesting period of the 2021 A-share incentive plan and the third vesting period of the 2022 A-share incentive plan, completed on January 29, 2026. Consequently, the board recommends changing the company's registered capital from RMB 1.778 billion (representing 1.778 billion shares) to RMB 1.837 billion (representing 1.837 billion shares).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171908312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 00:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171908312","market":"hk","top_or_hot":-1,"title":"PHARMARON Proposes Capital Increase","media":"Stock News","content":"<p>PHARMARON (03759) has announced that its board of directors has resolved and approved several proposals, including: (i) a recommendation to increase the company's registered capital; and (ii) a recommendation to amend the company's articles of association. This decision follows (i) the placement of a total of 58.4408 million new H shares on January 22, 2026; and (ii) the registration and listing of a total of 647,300 restricted A shares, which vested under the fourth vesting period of the 2021 A-share incentive plan and the third vesting period of the 2022 A-share incentive plan, completed on January 29, 2026. Consequently, the board recommends changing the company's registered capital from RMB 1.778 billion (representing 1.778 billion shares) to RMB 1.837 billion (representing 1.837 billion shares).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PHARMARON Proposes Capital Increase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPHARMARON Proposes Capital Increase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-31 00:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PHARMARON (03759) has announced that its board of directors has resolved and approved several proposals, including: (i) a recommendation to increase the company's registered capital; and (ii) a recommendation to amend the company's articles of association. This decision follows (i) the placement of a total of 58.4408 million new H shares on January 22, 2026; and (ii) the registration and listing of a total of 647,300 restricted A shares, which vested under the fourth vesting period of the 2021 A-share incentive plan and the third vesting period of the 2022 A-share incentive plan, completed on January 29, 2026. Consequently, the board recommends changing the company's registered capital from RMB 1.778 billion (representing 1.778 billion shares) to RMB 1.837 billion (representing 1.837 billion shares).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1171908312","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171908312","pubTimestamp":1774886722,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"PHARMARON (03759) has announced that its board of directors has resolved and approved several proposals, including: (i) a recommendation to increase the company's registered capital; and (ii) a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","03759":"康龙化成","BK1141":"生命科学工具和服务","BK0216":"研究试验","BK1576":"医药外包概念"},"translate_title":"康龙化成拟增资","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03759":1},"content_text":"PHARMARON (03759) has announced that its board of directors has resolved and approved several proposals, including: (i) a recommendation to increase the company's registered capital; and (ii) a recommendation to amend the company's articles of association. This decision follows (i) the placement of a total of 58.4408 million new H shares on January 22, 2026; and (ii) the registration and listing of a total of 647,300 restricted A shares, which vested under the fourth vesting period of the 2021 A-share incentive plan and the third vesting period of the 2022 A-share incentive plan, completed on January 29, 2026. Consequently, the board recommends changing the company's registered capital from RMB 1.778 billion (representing 1.778 billion shares) to RMB 1.837 billion (representing 1.837 billion shares).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171908312","isCrawlerRequest":true}